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Abstract 
Hospitalization and revascularization treatment for patients with acute myocardial 
infarction (AMI) is an economic burden that can be minimized by identifying patients most 
likely to benefit. To this end, a non-invasive imaging technique to better characterize 
myocardial salvage may be helpful. In this thesis work, a functional CT technique is 
examined to assess at-risk, infarcted, and salvageable myocardial tissue. Data was acquired 
on a cohort of seven pigs with induced AMI during the acute and sub-acute phases post 
insult. The tracer kinetic model dependent CT images were validated against both T2-TIRM 
images and quantitative T1-maps acquired using MRI, as well as constant infusion CT 
images. Extravascular contrast distribution volume (ECDV) and myocardial perfusion (MP) 
parameters were used to characterize the injured myocardium. Derived ECDV and MP 
threshold for acute phase MI in seven pigs is 0.36 ml/g and 0.44 ml/min/g, respectively. 
Average MP in normal, at-risk and infarcted myocardium were 0.92  0.27, 0.80  0.19, 0.30 
 0.08 ml/min/g, respectively. Average ECDV in normal, at-risk, and infarcted myocardium 
were 0.13  0.08, 0.21  0.07, 0.60  0.12 ml/g, respectively. Significance was demonstrated 
in both MP and ECDV measurements between infarcted myocardium and myocardium at-
risk, as well as between infarcted and normal myocardium (p< 0.01). Based on the area 
estimated using ECDV and MP, at-risk, infarcted, and salvageable myocardial tissue can be 
delineated. 
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CHAPTER 1  
1 INTRODUCTION 
Acute myocardial infarction is the leading cause of death in Western countries. It 
remains a significant problem with great economic burden dedicated to patient 
management and treatment. Therefore, a guideline to triage patients for 
revascularization treatment will be of tremendous value for those involved in this 
process. 
1.1 Acute Myocardial Infarction: A consequence of coronary 
artery disease 
Coronary artery disease (CAD) occurs when one or more of the three main arteries 
supplying oxygen and nutrients to the heart muscle become damaged (1). Acute 
myocardial infarction (AMI) or heart attack is a consequence of CAD. It develops when 
regions of the heart become necrotic due to shortage of oxygen required for cellular 
metabolism, with prolonged ischemia (restricted blood supply). The majority of AMI 
events (9 out of 10) are caused by atherosclerosis, which is defined as the build-up of 
plaques that narrow or occlude a portion of the blood vessel (2). However, AMI is most 
often caused by an abrupt blockage of the vessel due to the rupturing of vulnerable 
plaque. This restricts the delivery of nutrients and causes ischemic injury that impairs the 
myocardium downstream of the occlusion site. Ischemic injury continues to advance until 
the affected artery is treated and blood supply is restored. If revascularization treatment is 
not pursued, perfusion to the myocardium will not be restored. 
The severity of myocardial damage is dependent on the duration of unrelieved ischemia 
(3). Permanently irreversible damage (infarction) follows when the occlusion remains 
unresolved. Dense fibrous scar tissue takes the place of infarcted myocardium over time, 
and cardiac function becomes impaired. Symptoms of AMI are highly variable among the 
patient population. Common symptoms include chest and upper body discomfort, sweat, 
nausea, shortness of breath, and light-headedness. Some studies correlate the occurrence 
of AMI to time of day, with a greater incidence during the early morning hours as a 
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response to increased heart rate, blood pressure, and cardiac output in comparison to the 
later hours of the day (4). The symptoms listed above are common amongst many disease 
types. Hence, diagnosis and treatment planning remain ambiguous with clinical 
symptoms alone. 
The aim of chapter one is to present the global burden of heart disease. It will define the 
group of patients who are most likely in need of further functional tests for conclusive 
diagnosis, and revascularization treatment guidance. Furthermore, the imaging techniques 
that are currently available and practiced in clinic for the assessment of AMI will be 
discussed; as well as the clinical implications of the novel functional CT technique 
described in chapter two, with the potential to triage patients for revascularization 
treatment. 
1.1.1  Prevalence, mortality and economic burden of CAD 
Diseases of the heart are the leading cause of death in the United States with 27.6 million 
diagnosed Americans (5,6). Within this population, approximately 610, 000 lives are lost 
to heart disease annually. In Canada, one in every twelve Canadian adults over the age of 
21 is diagnosed with heart disease, and it is identified as the second leading cause of 
death with approximately fifty thousand individuals (7,8); this number represents twenty 
percent of the total number of deaths in 2013, as indicated by Statistics Canada. Heart 
disease is not prominent in one sex over another – it affects men and women equally. It is 
also agreed that the prevalence of the disease increases with age.  
Heart disease makes up the majority of cardiovascular disease (CVD). Generally, CVD 
refers to different conditions that involve the loss of perfusion to different organ tissues 
that constitute the cardiovascular system. This includes CAD, heart failure, stroke, and 
hypertension. The American Heart Association and the American College of 
Cardiology’s (AHA/ACC) 2018 statistical update suggests at least 130 million American 
adults are expected to be diagnosed with a form of CVD by the year 2035, by which time 
point the economic burden of CVD is estimated to reach $1.1 trillion per year (6). The 
majority of this cost is attributed to hospitalization and treatment of the diseased patients. 
Within the CVD population, 43.8% of deaths are associated with CAD, making it the 
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most common form of heart disease (9). In Canada, AMI caused by CAD is one of the 
top five reasons for inpatient hospitalization (10). Between the years 2016 and 2017, 
seventy thousand patients were hospitalized for an average of five days.   
Currently, patients require comprehensive assessment upon arrival at the hospital. In 
certain cases, these patients are left untreated because they yield inconclusive results. 
This can potentially extend beyond the window of opportunity for revascularization 
treatment for patients who require immediate attention. To reduce the time between 
patient arrival at the hospital and transfer to the catherization lab, it is crucial to challenge 
current clinical guidelines in place for AMI patients, such that the most practical methods 
can be implemented to aid those in need of intervention, while limiting hospital expenses.  
1.1.2 Management of acute coronary syndrome 
Acute coronary syndrome (ACS) is an umbrella term that summarizes three conditions 
that result in a reduction of blood supply to the myocardium due to an abrupt blockage. 
Figure 1-1 provides an overview of the three ACS categories characterized based on 
electrocardiographic (ECG) recordings and blood work: ST segment elevation 
myocardial infarction (STEMI), non-ST segment elevation myocardial infarction 
(NSTEMI), and unstable angina (UA). When ACS is suspected, the 2014 AHA/ACC 
guidelines for management of patients with ACS suggest ECG tracings be acquired 
within 10 minute of hospital admission and monitored sporadically at 15 to 30-minute 
intervals to observe the dynamic changes in the presence of ischemic episodes (11). 
Prolonged ST-segment elevation that deviates from previous baseline tracings is 
indicative of abrupt epicardial coronary artery occlusion(s) resulting in myocardial injury. 
Patients with STEMI are those with complete occlusions. These patients are unstable and 
urgently require revascularization treatment (11-13).  
On the other hand, ACS patients who show no elevation of the ST segment require 
further testing before they can be classified into NSTEMI and UA. The ST-segment in 
this group of patients is not as prominent or distinct because the occlusion is partial or 
temporary. Blood tests are typically performed to determine the concentration of cardiac 
4 
 
biomarkers, such as troponin. Cardiac troponin is expressed exclusively in the heart and 
is effective in differentiating UA and NSTEMI. Levels of troponin T and troponin I are 
sensitive and specific indicators of myocardial damage that transpires with AMI (14,15); 
the greater the concentration of troponin T and I, the greater the volume of myocardial 
necrosis. For patients suspected of NSTEMI or UA, both the ECG and troponin levels are 
monitored at baseline (arrival) and throughout hospitalization, as changes in biomarker 
concentration can provide an understanding of the degree of myocardial impairment. 
Change of twenty percent or more from baseline troponin level are considered a 
significant increase. Patients presenting this change are classified as NSTEMI. 
The third subcategory of interest comprises the patients with UA. Patients with UA have 
symptoms of severe, repeated chest pain that can potentially progress to myocardial 
infarction when left untreated. As UA patients have not experienced a heart attack or 
ischemia, troponin levels remain relatively stable over time—change less than 3 standard 
deviation between successive measurements—yielding inconclusive results. 
 
Figure 1-1 Categorization of STEMI, NSTEMI, and UA within ACS. Each subtype 
can be identified by ECG readings and blood sampling for cardiac biomarkers. 
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Because the combination of ECG tracings and troponin-level measurements yield 
inconclusive results, an additional non-invasive functional test is required to facilitate 
optimal patient management. This is especially important as statistics indicate two 
percent of patients discharged after presenting with asymptomatic serial ECG, biomarker, 
patient history, are later diagnosed with MI with greater risk of mortality (16,17). For 
these patients suspected of future episodes of MI, a non-invasive imaging technique may 
prove to be an advantageous diagnostic tool that can further characterize ischemically 
injured tissue to triage patients for revascularization treatment. 
1.1.3 Revascularization treatment  
When diagnosed with AMI, patients undergo revascularization via percutaneous coronary 
intervention (PCI, formerly known as coronary angioplasty). PCI is the primary non-
surgical choice of treatment for AMI patients. This treatment requires cardiac 
catheterization, where a balloon catheter is advanced through the arm or groin, and 
guided to the region of occlusion by fluoroscopy. For structure support and guidance 
through the anatomical vessel, the balloon is placed within a metal stent. The balloon is 
inflated once the catheter traverses the stenosis to allow revascularization by compressing 
the plaque mass to the walls of the artery. When blood supply is restored in the 
myocardium in a timely manner, revascularization treatment is deemed successful and 
can prevent irreversible damage. 
PCI is the preferred treatment for STEMI patients who present at the hospital within 2 
hours post symptom onset (18). For best clinical outcome, PCI treatment should be 
performed within 120 minutes of diagnosis (19,20). In general, as in stroke studies, time 
delay or ischemic time is shown to be directly proportional to infarct size (21). 
Consequently, the left ventricular function (a measure of global cardiac function) become 
inversely proportional to time to revascularization in AMI (3,21,22). 
Coronary artery bypass grafting surgery (CABG) is an invasive form of revascularization 
treatment, which is the most common open-heart surgery for NSTEMI-AMI patients. 
Briefly, a healthy artery or vein harvested from elsewhere in the body is grafted to bypass 
the blocked coronary artery thereby providing a new pathway for blood to access the 
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myocardium. Although PCI is a reference procedure for revascularization, previous 
clinical trials indicate CABG as the main standard of care for patients with complex 
disease when multiple vessels are occluded (23).  
1.1.4 Progressive changes in myocardial perfusion post AMI 
Coronary blood flow is directly proportional to the oxygen requirement or consumption 
of the heart. When the heart is stressed (e.g. exercise), the heart demands greater 
concentration of oxygen, compensated by more coronary blood flow. With partial 
occlusion of the artery, minimal oxygen is delivered through the occluded artery to meet 
the energy required by the heart to maintain function. In STEMI subjects with a complete 
occlusion, perfusion to the downstream muscles of the heart is completely lost in the 
coronary artery responsible for nutrient delivery. The muscle’s alternative source of 
oxygen supply is dependent on the development of collateral vessels, which also has an 
upper limit. Collateral vessels can compensate the loss of coronary blood flow, but its 
ability to maintain high demands of oxygen is determined by the advancement of the 
collateral vessels of the subject. During the progression of AMI and the formation of a 
complete occlusion, myocardial perfusion is lost with time. In addition, with greater 
regions affected by MI there are greater degrees of microvascular obstruction (MVO) or 
damage. The delivery of blood through the microvasculature is absent in tissue with 
MVO. 
1.1.5 Pathophysiology of AMI and myocardial edema 
As discussed in section 1.1, AMI is caused by the blockage of an artery that supplies 
blood to the heart. MI is the death of cardiomyocytes after extended oxygen deprivation 
or ischemia. Infarcted myocardium cannot be salvaged because the adverse effects of 
ischemic injury are detrimental. In contrast, myocardium at risk (MAR) that surround the 
infarcted myocardium is not yet necrotic and can be salvaged when reperfused promptly. 
Myocardial edema occurs in regions of MAR in the event of ischemia; however, edema 
further extends in injured myocardium with revascularization after acute MI event. 
Edema is a physiological response of interest for this project as it targets the patient with 
partial or temporary stenosis with experienced ischemia and reperfusion. Following 
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occlusion, the loss of blood flow downstream results in limited delivery of oxygen to the 
tissue. Oxygen is an important reactant that the body requires to undergo a metabolic 
process for the production of adenosine triphosphate (ATP), a major energy source 
powering all other cellular processes in the human body. This metabolic process is 
referred to as cellular respiration, where the body uses stored sugar molecules of glucose 
and the available intake of oxygen to produce energy rich ATP (13,24-26). 
ATP plays an important role in regulating the influx of water between the interstitial and 
cellular space. The ATP dependent sodium-potassium (Na+/K+) pump regulates the 
concentration of sodium and potassium inside and outside of the cell. For every three 
sodium ions extruding from the cell, two potassium ions enter the cell through the Na+/K+ 
pump. In the absence of oxygen, the concentration of ATP is reduced because the cell is 
unable to undergo cellular respiration. As a result, the ATP-dependent Na+/K+ pump 
becomes dysfunctional and leaky, allowing water to diffuse into the cell during the 
transportation of sodium ions (Figure 1-2) (25,26). 
In normal myocardium, eighty percent of the myocardium is composed of water. Of this 
water, 78% are water molecules that are tightly bound to proteins and other 
 
Figure 1-2 Normal myocyte in the absence of ischemic injury (left). Injured myocyte 
resulting from ischemic injury (right). Dash lines represent the loss of cell membrane 
integrity, making the surface of the cell membrane highly permeable 
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macromolecules (e.g. ribonucleic acid) within the myocyte. In oxygen deficient 
circumstances, the cell can alternatively depend on anaerobic respiration to produce a 
weaker source of energy, nicotinamide adenine dinucleotide (NAD+). NAD+ plays an 
important role in energy metabolism when oxygen is not readily available in the body 
system during environmental stress. Unfortunately, anaerobic respiration can only be 
effective for a short duration, when tissues are deprived of oxygen and a ‘plan b’ is 
required to maintain homeostasis. With prolonged occlusion where the supply of oxygen 
is insufficient relative to the tissue demand, anaerobic respiration can have detrimental 
effects on a molecular level.  
A byproduct of anaerobic respiration is lactate. The sudden demand for anaerobic 
respiration increases the concentration of lactate in the cell, forcing the intracellular 
environment to be acidic. With abrupt decrease in pH, the proteins and macromolecules 
that bind to the water molecules undergo a conformational change, which releases the 
water molecules allowing localization throughout the intracellular space. 
 
Figure 1-3 Fluid accumulation in the interstitial space of myocardium has two 
sources: blood vessel (capillary) and free water molecules of the cell via 
extracellular osmotic pressure forcing fluid to exit into the interstitial space. 
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Free water molecules in combination with the Na+/K+ pump malfunction are the main 
cause of cellular edema – the abnormal accumulation of water in a tissue – in the 
myocardium post AMI. It is important to note that edema in the myocardium takes place 
not only in the intracellular space but also in the interstitial space of the tissue. 
Fluid accumulation in the interstitial space has two sources (Figure 1-3). The main source 
of water is the blood vessel. Edema is the aftermath of an inflammation response to 
stress, a precursor of Na+/K+ pump dysfunction. Like the Na+/K+ pump of a myocyte, 
Na+/K+ pumps are present around the cell membranes of endothelial cells that line the 
interior surface of the blood vessels. With ischemia, capillary membranes become semi-
permeable due to the damage of endothelial cells. This means that following AMI, the 
endothelial cells undergo apoptosis, no longer able to guard the blood vessel from 
allowing the entrance and evacuation of unwanted materials. The capillary membrane 
becomes leaky, allowing fluid exchange between the vascular and interstitial space.  
In addition to the leakiness of the blood vessels, the second source of edema in the 
interstitial space is the osmotic pressure gradient between the intracellular and 
extracellular space, forcing fluid to diffuse out of the edematous myocytes into its 
neighboring interstitial compartment (Figure 1-3).  
 
Figure 1-4 The wave front phenomenon with initial ischemic and most affected area 
being the subendocardial region followed by subepicardial zone when a patient is left 
untreated. Myocardium at-risk (MAR) is the total area of tissue that is infarcted 
(irreversible injury) and can be salvaged (reversible injury). Assessment of MAR and 
infarcted myocardium will provide an estimate of how much tissue can be salvaged 
with intervention. 
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Previous animal studies have shown that myocardial infarction follows a ‘wave front 
phenomenon’, where the subendocardial regions of the heart are most affected by 
ischemia and are first to become infarcted (27). Followed by the subendocardial regions 
is the subepicardial layer or the extended borders of the myocardium at risk (MAR) 
(Figure 1-4). Common characteristics of infarcted myocardium are the presence of 
myofibrillar contraction bands, damaged mitochondria (either swollen or ruptured), 
microvascular obstruction, and haemorrhage (27-29). The duration of unrelieved 
ischemia will influence the presence and continuance of ischemic/reperfusion injury. 
Comprehensive assessment of the injured tissue prior to proceeding with treatment is 
necessary to reason how much tissue is at risk and infarcted to estimate how much can be 
salvaged. 
1.2 Diagnostic imaging for early detection of AMI 
As stated in section 1.1.2, a non-invasive imaging technique may prove useful in tissue 
characterization for NSTEMI and UA patients with inconclusive results during the 
primary examinations performed upon arrival at the emergency department. Diagnostic 
imaging techniques take advantage of the cascade of physiological events that occur 
during hypoperfusion and reperfusion, to evaluate myocardial tissue state. Three tissue 
states of interest are infarcted and salvageable tissue, which together represent at-risk 
myocardium. This section will briefly describe the most commonly used imaging 
techniques for cardiac tissue evaluation as well as techniques to measure cardiac 
function. The following imaging techniques are used to evaluate CAD in both acute and 
chronic stages of MI. Not all of these techniques are routinely practiced for diagnosis of 
AMI (the focus of this thesis work). Echocardiography, single photon emission computed 
tomography (SPECT), magnetic resonance imaging (MRI), and x-ray computed 
tomography (CT) are common modalities for cardiac imaging. The preference of one 
imaging method over another is based on the specific information that the user wants to 
acquire. Three types of assessments are of importance: anatomical, mechanical, and 
functional. The purpose of an anatomical assessment in AMI is to examine the degree of 
lumen narrowing. Mechanical assessment can provide wall-motion abnormality 
information. The most direct assessment of tissue state (quantity of reversible tissue 
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relative to necrotic tissue) is by acquiring functional data.  In the following section, the 
most prominent imaging modalities, and their role in assessing AMI will be discussed 
briefly. 
1.2.1 Echocardiography 
Echocardiography is a noninvasive imaging tool that is available at the bedside to 
visualize myocardial wall function during an ischemic process. Two-dimensional (2D) 
images are produced by the use of ultrasound for anatomical assessment, as well as 
myocardial function. Although echocardiography is not commonly used in diagnosing 
patients with AMI, echocardiography is a staple in clinical cardiology. In patients 
suspected of AMI, this imaging tool can locate abnormalities in wall motion (for 
example, myocardial stunning) and myocardial thickness. Echocardiography can also be 
used as a monitoring tool at the bedside to locate mechanical complications after MI 
event, to determine if a patient needs further treatment.  
To improve contrast between ventricle and myocardium, technologist can choose to 
intravenously administer the patient with microsphere contrast agents. Echocardiographic 
contrast agents approved and used in clinic are Optison and Definity which are perflutren 
protein type A and perflutren lipid microspheres, respectively. Contrast echocardiography 
is useful it that it can also provide perfusion information in real time. Previous studies 
have proven the use of contrast echocardiography pre- and post- revascularization to 
assess the area at risk, in addition to infarct size (30).  Overall, echocardiography of the 
heart is a practical approach to estimate global cardiac function of a patient; but a major 
limitation of this imaging technique worth mentioning is its high variance in image 
quality between operators. 
1.2.2 Cardiac magnetic resonance imaging 
MRI is used to investigate CAD in both acute and chronic MI. In diseases, such as stroke 
and AMI, MRI has been used to characterize tissue state with sufficient spatial resolution 
and excellent soft tissue contrast. In this section, two MRI techniques: gadolinium 
enhanced T1-mapping and T2-weighted (T2-w) imaging used to image myocardial 
viability will be discussed, with respect to its application for MI. 
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1.2.2.1 Post gadolinium enhanced T1-mapping 
Gadolinium enhanced T1 mapping has been used for tissue characterization and 
assessment of myocardial viability (31,32). As the name suggests, it requires the 
administration of exogenous extracellular contrast agents to improve sensitivity. 
Gadolinium-DTPA (diethylenetriamine penta-acetic acid) is a Food and Drug 
Administration (FDA) approved contrast agent used in MR imaging, and is used to 
shorten the T1 spin-lattice relaxation time. Gd-DTPA accumulates in injured 
myocardium as a result of increased permeability in the interstitial and cellular space 
after AMI. Therefore, injured myocardium with retention of Gd-DTPA will appear 
hypoenhanced in gadolinium enhanced T1-maps; and can be delineated as MAR.  
A limitation of gadolinium-enhanced imaging is the introduction of exogenous contrast 
agent to the body. Although it is a tracer amount of contrast, with the assumption that it 
takes no part in any physiological processes, it becomes problematic in patients subjected 
to renal failure. In patients with poor kidney function, gadolinium will retain in the body 
and cannot be cleared. This is a potential risk factor to consider in patients with history of 
kidney disease. 
1.2.2.2 T2-weighted imaging 
T2-weighted cardiac magnetic resonance imaging is sensitive to free water molecules in 
tissue. In AMI, it is useful in direct assessment of tissue edema (a marker of myocardium 
at risk of further infarction) (33). With this imaging technique, fluid filled regions of the 
tissue appear hyperenhanced relative to remote normal myocardium. It is a useful tool in 
delineating MAR in acute stages of MI, when myocardial edema is most prominent. MRI 
scientists have demonstrated the reduction in fluid over time after investigation of 
patients with MI at acute and chronic stages after ischemic insult (34).  
T1-mapping to detect infarct and T2-w imaging to delineate MAR is shown to improve 
diagnostic accuracy in identifying tissue with reversible injury (24). Although this 
technique is practiced in the clinic, it is not practical in emergency settings since the MRI 
scanner is not accessible in most hospitals around the clock, and requires highly trained 
operators. 
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1.2.3 Single Photon Emission Computed Tomography  
SPECT imaging is frequently used in clinic to assess myocardial perfusion for the 
evaluation of CAD. It is a nuclear medicine tomographic imaging technique which uses 
gamma rays and a gamma camera. A radioactive tracer – typically containing 
Technitium-99m or Fluorine-18 – is injected into the patient and the scanner detects 
gamma rays that are emitted by the tracer within the body. SPECT imaging is commonly 
combined with stress testing in patients with angina symptoms to reveal hemodynamic 
information prior to revascularization (37). This allows for comparison of myocardial 
perfusion measurements in myocardium at stress and myocardium at rest. The significant 
change in myocardial perfusion between stress and rest provide information on the degree 
of myocardial damage. Limitations of SPECT imaging is its sensitivity and radiation dose 
of approximately 4.5 mSv; which is higher than DCE-CT (3 mSv). 
1.2.4 Coronary computed tomography  
CT scanners have become one of the most available diagnostic and screening tools 
available in the hospital around the clock over the past decade. Their use has become 
more prominent with the ability to acquire axial and helical diagnostic images within 
seconds, facilitating patient throughput. Recent advances in CT technology have enabled 
the acquisition of high-resolution three-dimensional coronary angiograms in time periods 
shorter than fifteen minutes, including preparation time.  
Coronary computed tomography angiography (CCTA) uses x-ray beams and exogenous 
contrast agents, such as iodine, at high tube current for anatomical assessment with great 
accuracy. The greatest advantage of CCTA is its ability to detect the site of stenosis and 
the degree of lumen narrowing at the site of interest. It is time efficient and noninvasive, 
while remaining an effective diagnostic approach (35). However, although CCTA is 
highly sensitive to the localization of the occlusion by imaging the distribution of contrast 
agent in the blood vessel and identifying the hypoenhanced region (site of occlusion 
where iodine cannot enter), it is not useful in evaluating the haemodynamic influence of 
the stenosis on the downstream myocardium. In other words, CCTA is not a tissue 
viability test and can only identify the presence of stenosis. Multicenter studies have 
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praised its ability to detect occlusion sites but have criticized its high negative predictive 
value with regards to assessing physiological ischemia (36,37).  
To triage AMI patients for revascularization treatment, tissue viability (i.e. how much 
tissue can potentially be salvaged) is of interest. To do so, functional physiological 
parameters must be considered (38). For example, studies have emphasized perfusion 
measurements that can be obtained in conjunction with CCTA for improved evaluation of 
CAD severity, as 50% of stenosis located using CCTA alone is a poor predictor of 
ischemic injury (39,40). 
1.2.5 Dual energy computed tomography 
Spectral imaging or dual energy CT is a type of CT protocol that utilizes two different 
energy spectra (typically, 80 kVp and 140 kVp for clinical application). The main 
advantage of dual energy CT is its ability to decompose different anatomical features (i.e. 
differentiating bone, water, and blood vessels) (41). Material of unknown composition 
can be represented as a ratio of previously determined elements. Typically, the reference 
elemental composition of known value is water and iodine (exogenous extracellular CT 
contrast agent); and an unknown material would be identified as the ratio of water and 
iodine concentration. 
A research topic of interest in MI to study the chronic stages post MI is the use of ‘iodine 
mapping’ to detect scar tissue (42). Iodine mapping is a static image acquired at peak 
enhancement of contrast in the tissue to quantify the amount of iodine concentration 
within a single pixel of the acquired image. Like MRI, CT requires the intravenous 
injection of exogenous iodine contrast agents, which is retained in the extracellular space 
of injured tissue. With basic knowledge of water and iodine density, iodine mapping can 
make use of material decomposition to quantify the ratio of iodine to water concentration 
within a single pixel to detect injured tissue and perfusion defects (43).The accumulation 
of contrast in the injured myocardium  is the consequence of myocardium remodeling at 
the chronic stages of MI due to the dense fibrotic tissue content in the extracellular space. 
The myocardium region where scar and fibrosis are present would appear hyperenhanced 
with greater accumulation of iodine. 
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An additional advantage of dual energy CT is its ability to reduce artifacts such as beam-
hardening effects (38). Beam hardening occurs as a result of greater attenuation of low 
energy x-ray beams than higher energy x-ray beams. The average x-ray after the beam 
passes the material will be higher due to this, i.e. hardening of the beam. This artifact can 
be corrected during image reconstruction by producing a virtual monochromatic image at 
a single energy (38,44). 
1.2.6 Dynamic contrast enhanced computed tomography 
Dynamic contrast enhanced (DCE) – CT is a functional imaging technique where a 
patient is injected with contrast and the enhancement of contrast in the organ of interest is 
monitored over time. During a dynamic imaging session of the heart, prospective ECG-
gating is used to acquire a set of scan images at the same diastolic phase of the cardiac 
cycle (Figure 1-5). It provides functional information on the hemodynamics of the 
myocardium that cannot be acquired from a standard anatomical CT (45). Previously, 
DCE-CT images of the heart were acquired with retrospective ECG-gating technique, 
where the subjects were scanned during the whole cardiac cycle. Images were 
reconstructed retrospectively at a single cardiac cycle. With the advancement of 
prospective ECG-gating where a single scan is acquired at a specific phase of the cardiac 
cycle, the effective dose of radiation to the patient has been reduced from 12 mSv to 
3mSv. 
 
Figure 1-5 Ventilation suspension two seconds prior to a cardiac cycle and the scan 
performed at the diastolic phase of the cardiac cycle (at 75% R-R interval). 
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DCE-CT can be achieved using either a single energy or a dual energy CT to obtain 
quantitative functional data. Single energy DCE-CT requires advanced post image 
processing methods to correct for beam hardening effect. As mentioned in section 1.2.4, 
dual energy CT may have an advantage over single energy CT; for example, beam 
hardening correction and material decomposition.  
A contrast-enhanced image of an organ of interest is not enough to yield functional 
information. Tracer kinetic modeling for dynamic CT has been developed and used 
extensively in the evaluation of tissue hemodynamics. A tracer kinetic model must be 
applied to the time enhancement curve (in Hounsfield unit, HU) of the tissue and artery to 
 
Figure 1-6 General time enhancement curve acquired during DCE-CT study of tissue 
(Q(t)) and arterial input (Ca(t)) used to derive functional parameters. Rapid scanning in 
the first phase is to ensure the wash-in of contrast agent is accurately measured. The 
second and third phase of the scan is at wider intervals to monitor the retention and 
slow wash out of contrast from the myocardium. 
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derive functional parameters such as perfusion (blood flow), blood volume, and mean 
transit time (Figure 1-6). This will be further discussed in section 1.2.6 
1.2.6.1 Johnson Wilson Lee Model 
Our lab has pioneered the Johnson Wilson Lee (JWL) capillary-tissue kinetic model to 
facilitate quantitative measurement of tissue perfusion from a single bolus injection of 
contrast medium and dynamic imaging session (44, 46). It has been applied to measure 
myocardial perfusion in pigs with reperfused acute myocardial infarction and in patients 
with known or suspected coronary artery disease (44). The JWL model describes the 
kinetic behaviour of contrast medium in a single capillary transit in a realistic manner: 
Firstly, it assumes that the concentration of contrast in the vascular space (capillaries) is 
spatially non-uniform and has a concentration gradient from the arterial inlet to the 
venous outlet. This assumption accounts for the exchange of contrast medium between 
the vascular and interstitial spaces through passive diffusion during its first-pass 
circulation. Secondly, it assumes that the contrast concentration gradient in the radial 
direction within the vascular space is negligible compared to that in the axial direction 
(from arterial to venous ends), because the flow rate in the axial direction is much greater 
than that in the radial direction within the vascular space. Thirdly, the interstitium is 
assumed to be a compartment, in which the contrast residues in the interstitium is well 
mixed and the contrast concentration in the interstitial space is homogenous. This 
assumption holds true because the capillaries in tissue are oriented randomly, hence, 
contrast can enter the interstitial space in all directions which justified the assumption of 
uniform mixture of contrast in this compartment. Furthermore, the rate of contrast 
movement in the interstitium is much slower compared to the flow rate in the vasculature. 
The distribution of contrast medium within the myocardium is governed by two 
processes: (1) the wash-in and wash-out of contrast in and out of the vascular space via 
perfusion; (2) Passive diffusion of contrast between the vascular and the interstitial space 
through the permeable capillary endothelium. The bi-directional exchange of contrast 
between the vascular and interstitial spaces is governed by rate constants K1 and k2.  
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The dynamic CT images acquired after a bolus injection of contrast can measure the 
tissue and arterial time-enhancement curve (TEC). Together with tissue blood flow, K1 
and k2 can be estimated from the measured TECs using the JWL model. The tissue and 
arterial TEC have the following relationship: 
where Q(t) is the tissue TEC, F is the blood flow in tissue, Ca(t) is the arterial TEC,  is 
the convolution operator, R(t) is the impulse residue function (IRF), and RF(t) is the flow-
modified IRF. The IRF is the theoretical delta function that describes the tissue response 
to instantaneous delivery of contrast medium at the arterial inlet of the tissue. The height 
of IRF is unity. The flow-modified IRF has the following mathematical forms:  
 
Figure 1-7 Flow-modified one-compartment Johnson and Wilson model of tracer 
kinetics. K1 and k2 are the influx and efflux rate constants, P = permeability 
coefficient, S = total surface area, Vv = volume of contrast in the vascular space, F= 
local blood flow, Vi = volume of contrast in the interstitial space, Ca(t) = concentration 
of contrast in the input artery, Cv(t) = concentration of contrast in the output vein. 
 
Q(t) =  F  [Ca(t)  R(t)] 
        = Ca(t)  [F  R(t)] 
        = Ca(t)  RF(t) 
 
Eq. 1-1  
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where To is the contrast arrival time, W is the minimum transit time and Vi is the volume 
in the interstitial space. At time less than To, no contrast is delivered in the tissue and 
hence RF(t) remains zero. When contrast is delivered at the arterial inlet at To, RF(t) 
becomes F and remains as F for the time less than the minimum transit time, during 
which the contrast remains in the tissue. At time greater than W, a fraction of contrast is 
washed out at the venous end, and RF(t) is equal to the product of flow and extraction 
fraction (E) and an exponential term that describes the gradual decrease of contrast 
concentration in the tissue over time. 
1.2.6.2 Extended Johnson Wilson Lee Model 
CT contrast medium is an extracellular agent and metabolically inert, and does not 
distribute in tissue cells under normal condition. In the setting of acute myocardial 
infarction where the cell membrane integrity in injured myocardium is altered, CT 
contrast may gain access into the cellular space which may lead to a prolonged 
accumulation (47-51). To account for the kinetics behaviour of contrast in acutely injured 
myocardium, the JWL kinetic model is extended to simultaneously measure myocardial 
perfusion (MP) and extravascular contrast distribution volume (ECDV) (Figure 1-8). The 
latter parameter has a unit of mL per gram of tissue.  
k1 to k2 in equation 1-3 are the rate constants describing the diffusion of contrast from the 
vascular space to the interstitial space, and vice versa; k3 and k4 are the rate constants that 
describe the diffusion of contrast from the interstitial space to cellular space, and vice 
versa.  
The RF(t) has the following forms governed by the extended JWL model:  
RF(t) = {
0                                             0 ≤ t < T0
F                              T0 ≤ 𝑡 < T0 + W
F ∙ E ∙ e
-
F∙E
Vi
(t-W)
                     t > T0 + W
 
 
Eq. 1-2  
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RF(t) = {
F                                                  T0 ≤ t < T0 + W
F ∙ E                                                      t = T0 + W
G ∙ e-α(t-w-T0) + H ∙ e-β(t-w-T0)                  t > T0 + W
 
G = K1
k3 + k4 - α
β - α
  and  H = K1
β - k3 - k4
β - α
 
𝛼 =
(k
2
 +k3 + k4 ) − √(k2 +k3 + k4 )
2 − 4k2k4
2
 
𝛽 =
(k
2
 +k3 + k4 ) + √(k2 +k3 + k4 )
2 − 4k2k4
2
 
 
Eq. 1-3  
 
Figure 1-8 Flow-modified two-compartment extended Johnson Wilson Lee model of 
tracer kinetics to account for the exchange of contrast in the addition cellular 
compartment. The dash line outlining the cellular compartment represents the loss of 
cell membrane integrity in acutely injured cardiomyocytes, increasing contrast 
permeability. K1 = rate of influx from vascular compartment to interstitial 
compartment, k2 = rate of efflux from interstitial to vascular compartment, k3= rate of 
influx from interstitial to cellular compartment, k4= rate of efflux from cellular to 
interstitial compartment. P = permeability coefficient, S = total surface area, F= local 
blood flow, V = volume of contrast, Ca(t) = concentration of contrast in the input 
artery, Cv(t) = concentration of contrast in the output vein. 
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For time between To and To + W, the form of RF(t) described by the extended JWL model 
is identical to that described by the JWL model. The difference occurs at the time greater 
than To + W, where the gradual washout of contrast in the tissue is given by dual 
exponential terms in the extended JWL model to account for the involvement in both the 
interstitial and cellular compartments.  
In summary, ECDV in normal tissue (ECDVnormal) is equal to the volume of contrast in 
the interstitial compartment (Vi). ECDV in infarcted tissue (ECDVinfarct) is equal to the 
sum of the Vi and the volume in the cellular compartment (Vc). Thus, ECDV in infarcted 
tissue will be greater than in normal tissue:  
     ECDVnormal =  Vi ; 
     ECDVinfarct = Vi + Vc ; 
ECDVinfarct > ECDVnormal . 
 
1.3 Rationale and Clinical Translation 
AMI caused by partial or complete occlusion of one or more coronary arteries becomes 
an economic burden from the moment of admission to treatment and care, followed by 
re-hospitalization when required. Lack of blood flow and oxygen delivery are detrimental 
to the myocardium, causing edema in the injured myocardial tissue. Myocardial edema is 
a hallmark of the ischemic (hypo-perfused) myocardium that is at risk of irreversible 
injury (infarction), and can be assessed non-invasively with T2-w MRI. Imaging the at-
risk myocardium would be useful to inform decision making related to interventional 
revascularization treatment, particularly for patients who do not receive treatment 
promptly after a temporary or partial occlusion due to lack of evidence of salvageable 
myocardium Specifically, these patients include NSTEMI and UA patients described in 
ECDVinfarct = Vi + Vc =
G
α
+
H
β
 Eq. 1-4  
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section 1.1.2. However, MRI is typically not available in the emergency setting and is 
rarely used to assess patients with AMI. 
On the other hand, DCE CT is a fast imaging technique and has the potential of being 
widely available at hospitals; with many scanners sited in emergency departments. Our 
group has developed a functional CT method for measuring the distribution volume of 
contrast agent in the extravascular space of the myocardium and hypothesized that 
ECDV, assessed by CT, can be a surrogate marker of myocardial edema in MAR. 
1.4 Purpose and Hypothesis 
The purpose of my thesis is to validate ECDV estimated using the functional CT 
technique and to determine quantitative thresholds of ECDV and MP that can be used in 
delineating the extent of salvageable myocardium. The hypothesis of my work is that 
salvageable myocardium can be identified in DCE-CT as tissue that demonstrates the 
presence of edema with depressed blood flow, while infarcted myocardium exhibits 
marginal to no blood flow within the edematous region. 
1.5 Thesis Overview 
The overall objective of this research project is to demonstrate the potential use of DCE-
CT to delineate salvageable myocardium by simultaneous assessment of edema and 
myocardial perfusion in a single dynamic imaging session.  
In chapter 2, I validated the ECDV metric quantified using the extended JWL tracer 
kinetic model against the model independent constant infusion CT imaging method. We 
wanted to ensure that the ECDV estimated using a tracer kinetic model is a true surrogate 
of myocardial edema in injured myocardium after ischemic injury. After confirming 
ECDV as a marker of edema, I derived ECDV and MP thresholds on the same subjects 
used for validation at acute phase post AMI to delineate area of MAR, infarcted 
myocardium, and salvageable myocardium. Lastly, I compared the areas measured using 
the functional CT metrics to the area measured using the standard constant infusion CT 
technique to identify salvageable myocardium.  
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Chapter 2 is in preparation for submission as a paper to the Journal of the American 
College of Cardiology: Cardiovascular Imaging entitled “Functional CT Imaging to 
Identify Salvageable Myocardium for Acute Myocardial Infarction Management”. 
The last chapter (Chapter 3) summarizes the thesis results, discusses the limitations of the 
functional CT technique, and describe possible future work that will improve ECDV 
measurement. This thesis work will conclude by discussing the clinical translation of the 
functional CT technique. 
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CHAPTER 2  
2 Functional CT Imaging to Identify Salvageable 
Myocardium for Acute Myocardial Infarction 
Management 
2.1 Introduction 
Treatment for acute myocardial infarction (AMI) aims to restore flow to stenosed arteries 
by percutaneous coronary intervention (PCI). PCI is effective when the procedure is 
performed within the first 120 minutes from symptom onset but is most successful within 
the first 60 minutes (1). Beyond this time window, the amount of myocardial tissue that 
experiences irreversible damage significantly increases (2-5). Thus, rapid recognition of 
AMI is required to facilitate the prompt application of PCI and to maximize its success. 
Clinical symptoms and the incorporation of 12-lead electrocardiogram (ECG) are the 
primary basis for revascularization treatment decision-making (6). These initial 
assessments are sufficient to diagnose patients with ST-elevation myocardial infarction. 
However, for patients with non-ST elevation myocardial infarction and unstable angina, 
diagnosis cannot solely be made from knowledge of clinical symptoms and ECG-
tracings. These patients with partial occlusions have varying degrees of AMI but are 
often overlooked due to the lack of significance in their preliminary tests; missing the 
critical window for treatment.  
Many studies have explored the use of imaging to improve diagnosis and prognosis of 
AMI. Coronary computed tomography (CT) angiography can be useful in detecting the 
location and size of an occlusion (7-11). However, it yields no functional information on 
the hemodynamics or viability of the myocardium affected by the stenosis. The amount 
of salvageable myocardium estimated using functional imaging techniques is a useful 
metric for triaging patients; the more salvageable tissue, the more successful a 
revascularization treatment (12). Delayed contrast-enhanced imaging using CT and 
magnetic resonance imaging have shown promise in assessing myocardial viability by 
quantifying the retention of contrast agent at equilibrium following slow infusion (13-22). 
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However, this model-independent technique is impractical because of the time required to 
achieve equilibrium between the tissue and the arterial blood pool (typically an hour). 
An indicator of myocardial viability is the presence of salvageable myocardium, or 
myocardium that is edematous with reduced perfusion relative to normal myocardial 
tissue (23-28). In contrast, non-salvageable, infarcted myocardium is edematous but has 
marginal to no perfusion. Salvageable myocardium is likely to become infarcted if not 
addressed quickly.  
Recently, So et al. explored dynamic contrast enhanced (DCE) CT imaging to assess 
myocardial viability by simultaneously quantifying myocardial perfusion (MP) and 
edema (29). So et al. assumed that the extravascular contrast distribution volume (ECDV) 
within the injured myocardium could be a surrogate marker of edema. This metric is 
derived from the extended Johnson-Wilson-Lee (JWL) tracer kinetic model, but has not 
yet been validated by comparison to a model-independent technique. The present study 
aims to: (1) validate myocardial edema as measured by ECDV against the model-
independent constant infusion CT imaging method, (2) derive thresholds of MP and 
ECDV that can be used to quantify the amount salvageable myocardium, and (3) compare 
the use of thresholds against the standard constant infusion CT technique to identify 
salvageable myocardium. 
2.2 Methods  
2.2.1 Study design 
For this study, a porcine AMI model that exhibits injury ranging from edema to infarct 
was used. Although this model does not fully mimic clinical AMI, the range of injury is 
sufficient to evaluate different methods of myocardial tissue injury characterization. 
During the acute stage (3 days after AMI induction), the animals were imaged using both 
CT and MR. Pre-contrast and post-contrast infusion CT images were acquired to produce 
delayed contrast images of the heart. This constant contrast infusion technique provided a 
model-independent way of assessing myocardial viability as well as a standard for 
validating model-dependent metrics. T2-weighted turbo inversion recovery magnitude 
(TIRM) images were also acquired as a standard for validation. Dynamic contrast 
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enhanced CT images were acquired to obtain the model-dependent MP and ECDV 
metrics. T1 maps were acquired to derive the MP and ECDV thresholds. Imaging was 
repeated during the sub-acute stage (two weeks post-AMI induction). This study protocol 
was approved by the Western’s research ethics board. 
2.2.2 Animal model 
Seven female Landrace pigs (40-70 kg) were used in this study. AMI was induced using a 
catheter-based approach, where a balloon catheter was advanced to the distal left anterior 
descending artery (LAD) and inflated to obstruct the downstream perfusion for one hour; 
perfusion was restored after one hour. Anesthesia was induced by propofol (15-20 cc, 
Novapharm Ltd, Scarborough, Ontario, Canada) and maintained with 2.0% isoflurane 
(Baxter Corporation, Mississauga, Ontario, Canada). When required, Fentanyl (Sandoz 
Canada Inc., Boucherville, Quebec, Canada) was administered at a dose of 1-2 mL for 
pain relief. 
In preparation for imaging, the pig was anesthetized with 1ml/20kg Telazol (reconstituted 
with 5ml xylazine) IM. At 1.5 hours after initial administration of anesthetics, half the 
original dose was delivered to maintain heart rate. The ventilator was set at 
approximately 10 ml/kg (at a range of 7-15 ml/kg) to maintain low normal CO2 range, 
and respiratory rate at approximately 20 bpm. Heart rate, body temperature, and partial 
pressure of carbon dioxide were monitored and maintained throughout the course of the 
scan. Ventilation was suspended approximately 2 seconds prior to the image acquisition, 
as needed, to mimic breatholding. 
2.2.3 Data Acquisition 
2.2.3.1 Computed tomography imaging 
To assess injured tissue when edema is present at the acute and sub-acute stages, subjects 
were imaged on day 3 and day 12±3 post-AMI using CT. DCE-CT heart images were 
acquired with a 64-row CT750 HD scanner (GE Healthcare, Waukesha, Wisconsin) 
following a single bolus injection of iodine contrast agent (0.7 mL·kg-1 at 3 mL·s-1, 76% 
iopadimol, Isovue multipack-370). Scans were prospectively ECG gated and acquired in 
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the axial orientation, with a gantry speed of 0.35 s/rotation. A 3-phase protocol was used 
for image acquisition: 1st phase, 22 scans every 1-2 heart beats; 2nd phase, 6 scans 
acquired at approximately 14 s intervals; and 3rd phase, 4 scans acquired every 30 s. A 
dual energy technique (140/80 kVp; 0.2 ms and 630 mA) was used using a rapid 
switching x-ray tube.  
Next, reference CT images were acquired for the constant contrast infusion protocol. Five 
reference images were acquired prior to the infusion of the same dose of contrast agent 
(0.7 mL·kg-1, 76% iopadimol, Isovue multipack-370), which was infused intravenously 
over one hour. Another five images were acquired post contrast infusion when the 
concentration of contrast in the tissue and the arterial blood pool reached equilibrium. 
Equilibrium was confirmed by the state of no change in enhancement between the two 
compartments over time. For each acquisition, 16 2.5-mm thick slices were 
reconstructed.  
2.2.3.2 Magnetic resonance imaging  
2.2.3.2.1 T2-weighted imaging for edema 
T2-w images of the heart were acquired on the same day as the CT study using a 3-Tesla 
Siemens Magnetom Biograph mMR scanner (Siemens Healthcare, Erlangen, Germany). 
Similar to the CT study, each scan was acquired during the diastolic phase of the cardiac 
cycle following prospective ECG-gating. Ventilation was suspended for every slice 
location at approximately two seconds prior to scanning to mimic breatholding. The turbo 
inversion recovery magnitude sequence (TIRM), was used with the following scan 
parameters: 5 slices in the axial orientation; TE: 47ms; TR:1363ms; TI: 180ms; flip 
angle: 180; ETL: 12; matrix size: 256 x 256; slice thickness: 8mm. 
2.2.3.2.2 Gd enhanced T1-mapping for salvageable myocardium 
In addition, a gadopentetate dimeglumine contrast (Magnevist 0.1ml/kg) enhanced T1 
map was obtained with a modified Look-Locker sequence. Contrast agent was 
administered approximately 12 minutes prior to scanning and the scans were 
prospectively ECG-gated. The sequence parameters were: 202 ms acquisition window; 
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300ms trigger delay; three inversions at intervals of 80 ms; TR: 237.03ms; TE: 1.07ms; 
flip angle: 35°; ETL: 1; matrix size: 192 x 192.  The same 5 8-mm thick axial slices were 
imaged with both sequences. Ventilation was suspended for every slice location at 
approximately two seconds prior to the image acquisition to mimic breatholding. 
2.2.4 Data Analysis 
2.2.4.1 Dynamic contrast enhanced CT 
The CT projection data were reconstructed as 70 keV virtual monochromatic images (2.5 
mm thick) to reduce beam-hardening artifact. To reduce the effect of cardiac and 
respiratory motion, partial scan reconstruction (180 degrees plus the fan angle) was 
utilized. (A comparison of 360-degree reconstruction and partial reconstruction is 
provided in Appendix A). Reconstructed images were averaged to yield seven, 5-mm 
thick slices covering each subject’s heart. To remove the effects of residual cardiac and 
respiratory motion between scans, 3D images were registered using a 3D non-rigid 
registration algorithm (GE proprietary software) used on a GE advantage workstation 
(version 5.0.9). 
2.2.4.1.1 ECDV and MP functional maps 
For each slice, ECDV and MP functional maps were generated from a set of 70 keV 
virtual monochromatic DCE images using the extended JWL model of tracer kinetics, 
which was incorporated into the CT perfusion software (GE Healthcare). To extract an 
arterial input function Ca(t), a region of interest was manually drawn on the descending 
aorta of the axial images. Myocardial regions of interest were also drawn as described in 
section 2.2.4.3. The mathematical descriptions used to calculate ECDV and MP were 
published previously by So et al (29). Briefly, the upslope of the tissue curve in relation 
to the arterial curve of the descending aorta is used to estimate the absolute MP in 
ml/min/g of tissue; the area under the third phase (wash-out of contrast) of the curves are 
used to estimate the absolute ECDV in ml/g of tissue. Figure 2-1 shows a representative 
DCE-CT image, along with time-enhancement curves and resulting ECDV and MP 
functional maps. 
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2.2.4.2 Constant infusion CT 
The constant infusion CT images were acquired and used as the reference standard 
because it is a model-independent approach. The measured partition coefficient value is 
not derived from a mathematical model but are calculated at equilibrium between the 
tissue and the arterial blood pool. To improve the signal-to-noise ratio (SNR), adjacent 
slices of the constant infusion CT acquisition were averaged into 5 mm images. Next, 
images acquired pre and post contrast infusion were registered to each other using the 
proprietary 3D non-linear registration method provided by GE, and the five pre- and five 
post-infusion images were averaged to further increase the signal-to-noise ratio. A 
difference image for each slice location was generated by subtracting the average pre-
contrast image from the average post-contrast image, as shown in Figure 2-2; these 
difference images were then used to calculate the partition coefficient (PC) of the tissue 
at equilibrium. The change in signal intensity (SI) between the pre and post contrast 
images, SIpre and SIpost respectively, provides information on the accumulation of iodine 
contrast in different regions of the myocardium. Hence, PC is a surrogate marker of 
iodine distribution volume.  The partition coefficient is calculated as the volume 
distribution of contrast in the total tissue region of interest (SItissue) normalized to the 
 
Figure 2-1  ECDV map and MP map of the left ventricular myocardium of a sub-
acute phase infarcted pig post ischemic insults corresponding to the dynamic CT 
image. A time enhancement curve (left) of the different myocardium region outlined 
on the ECDV and MP map. The time enhancement curve of the injured tissue 
(orange) shows higher elevation than the remote during the delayed phase of the scan 
(50-250s), due to the retention of contrast agent.  
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arterial blood pool (SIarterial blood); i.e. PC = SItissue / SIarterial blood at equilibrium. An 
increase in PC in infarcted myocardium corresponds to an increased contrast distribution 
volume as a result of edema and the additional space in which contrast can accumulate. 
2.2.4.3 Assignment of coronary territory 
In the pig, the axial scan orientation results in myocardial images parallel to the 
horizontal long axis of the left ventricle (LV). Non-linearly registered DCE-CT images 
were averaged across time to produce a static image that was used to outline the inner and 
outer boundaries of the myocardium. These boundaries were used to define the 
myocardium on the functional maps as well as the CI difference image. The LV was 
divided into six segments based on the American Heart Association (AHA) horizontal 
long axis nomenclature (Figure 2-3) (30). The apical septal and apical lateral walls, 
shown in Figure 2-3 in purple and blue, respectively, are the regions supplied by the 
occluded LAD. Thus, these regions contain the injured tissue. The injured tissue, or the 
myocardium at-risk (MAR), is composed of both salvageable and infarcted myocardium. 
The mid-lateral wall, shown in yellow in Figure 2-3, is supplied by the patent LCx, and 
thus contains normal, uninjured tissue. The apical septal and the mid-lateral walls were 
used as regions of interest for validation of the functional CT technique at the acute and 
sub-acute phases after insult. The whole apical wall (septal + lateral walls) was used as a 
region of interest (ROI) to define the MP and ECDV thresholds.  
 
Figure 2-2 Difference image (right) generated by subtracting the pre-infusion image 
(center) from the post-infusion image (left). 
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2.2.4.4 Determination of MP and ECDV thresholds that define the 
myocardium at-risk area 
The MAR area was identified on T1 maps by selecting all pixels within the apical wall 
ROI with T1-values three standard deviations away from the average T1-value in the 
mid-lateral wall ROI. To find the corresponding MAR area within the CI difference 
images used to validate model-dependent metrics, a threshold of 30 HU was used, as this 
threshold consistently produced an MAR area that matched that measured with the T1-
map. All pixels above 30 HU were considered to be MAR in pigs without microvascular 
obstruction (non-MVO, n=2). 
In pigs with MVO (n=5), the threshold does not identify infarcted tissues, which are 
hypoenhanced due to lack of contrast delivery. However, these hypoenhanced regions 
were always surrounded by a hyperenhanced rim that is >30 HU. In these cases, the area 
of hyperenhanced rim was considered to be the area of salvageable myocardium, while 
 
Figure 2-3 Six segment horizontal long axis of the heart as defined by the AHA 
(30). These segments are supplied by the left anterior descending (LAD), right 
coronary (RCA), and the left circumflex (LCx) arteries.  
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the hypoenhanced area was considered as the area of infarct. The sum of the areas was 
the MAR area. 
To determine the ECDV functional map threshold that yielded an MAR area that agreed 
best with the MAR area determined from the CI images, the apical wall ROI in each slice 
was “flooded” at thresholds ranging from 0.30 ml/g to 0.50 ml/g. For each threshold, the 
combined area of all pixels above the threshold was calculated and compared to the MAR 
area determined from the CI difference images.  
A similar analysis was performed on the MP functional maps. The apical wall ROI in 
each slice was flooded at thresholds ranging between 0.36 ml/min/g and 0.5 0ml/min/g. 
This range of perfusion thresholds was selected based on previous studies showing that 
MP <0.50 ml/min/g delineates infarcted myocardium (45,48). For each threshold, the 
combined area of all pixels above the threshold was calculated and compared to the 
infarcted area determined from the CI difference images. Since the infarcted area can 
only be determined in cases with MVO, this comparison was restricted to MVO subjects 
only. These analyses were performed using the acute phase (3 days post-AMI) images 
only. 
2.2.4.5 Statistical analysis 
All statistical analyses were performed using GraphPad Prism 7 software. Using two 
tailed t-tests, ECDV, PC, and T2-TIRM signal intensity (SI) values in the apical septal 
wall territory were compared to the ECDV, PC, and T2-TIRM SI values in the mid-
lateral wall territory, respectively. Significance was determined by p <0.05. Comparisons 
were made with images acquired at the acute and sub-acute phases. Values were reported 
as means of each region and standard errors between subjects. 
To identify the ECDV and MP thresholds that yielded MAR and infarct areas that best 
agreed with the CI-defined areas, Bland-Altman analysis was performed for each 
threshold. The mean bias ± standard error was plotted as a function of threshold and 
linear regression was performed. The ECDV and MP thresholds that yielded zero bias 
according to the regression were selected as the thresholds that best separate injured from 
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uninjured tissue. Areas with ECDV greater than the threshold were considered 
myocardium at risk while areas with MP lower than the threshold were considered 
infarcted myocardium. The mean ECDV and MP values in MAR, infarcted myocardium, 
and normal myocardium were compared using two-tailed t-tests. 
The areas of the thresholded ECDV and MP pixels within the apical wall were compared 
to the MAR areas determined from the CI images. A comparison between the total area 
of all thresholded pixels within the apical wall made (ECDV + MP) and the CI-defined 
MAR area was also performed. These comparisons were made using two-tailed t-tests. 
Both MVO and non-MVO cases were analyzed. 
2.3 Results 
2.3.1.1 Validation of ECDV versus constant infusion 
The detection of the edematous region using the CT-derived ECDV functional map was 
comparable to that achieved using the CI difference image and the T2 TIRM image 
(Figure 2-4). ECDV in the apical septal wall during the acute (day 3) and sub-acute (day 
12±3) phases post-insult was 0.39±0.04 ml/g and 0.46±0.08ml/g, respectively. As shown 
in Figure 2-5, the ECDV in the mid-lateral wall was significantly lower than in the apical 
septal wall at both the acute (0.14±0.01ml/g) and sub-acute (0.24±0.08 ml/g) phases 
(p<0.05). Similarly, PC in the mid-lateral wall was significantly lower than that in the 
 
Figure 2-4 (A) ECDV MAR depicted in the apical septal wall corresponds to the 
enhanced region of on the CI difference image (B) and T2 TIRM image (C). Injured 
myocardium is shown by the enhanced region (red arrow). The normal, uninjured 
mid-lateral wall (green arrow) is not enhanced. 
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apical septal wall for both phases (acute: 0.77± 0.05 vs. 0.37±0.04 and sub-acute: 
0.80±0.04 vs. 0.37±0.01, p<0.05).  
Change in ECDV and PC between normal and MAR within each subject is shown in 
Figure 2-6. The same result was also observed in the T2-TIRM images. The signal 
   
Figure 2-5 (top) ECDV (ml/g) in infarcted and normal myocardium at acute and sub-
acute stages post insult. (center) PC in infarcted and normal myocardium at acute and 
sub-acute stages post insult. (bottom) T2 TIRM signal intensity (a.u) in infarcted and 
normal myocardium at acute and sub-acute stages post insult. Error bars represent 
standard error amongst the subjects (* denotes p < 0.05). Injured myocardium is 
represented by the apical-septal wall and the uninjured normal myocardium is 
represented by the mid-lateral wall. 
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intensities in the mid-lateral wall were significantly lower than the signal intensities in 
the apical septal wall for both the acute and sub-acute phases. The corresponding signal 
intensities in the at-risk and normal myocardium on acute and sub-acute phase T2 TIRM 
images were 77.8±21.0 vs. 41.9±14.4 and 65.6±9.20 vs. 34.0±9.68 (p<0.05), 
respectively. 
2.3.1.2 ECDV and MP thresholds 
The mean bias between the thresholded ECDV area and the CI-derived MAR area are 
plotted with respect to ECDV threshold value in Figure 2-7, along with the mean bias 
between the thresholded MP area and the CI-derived infarct area, which are plotted with 
  
Figure 2-6 (top) Difference of partition coefficient between MAR and remote 
normal tissue is shown for each of the seven pigs at the acute and sub-acute phases. 
(bottom) The same trends are seen for ECDV. (* denotes p < 0.05). 
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respect to MP threshold. Linear fitting determined that an ECDV threshold of 0.36 ml/g 
and an MP threshold of 0.44 ml/min/g resulted in a mean bias of zero. The corresponding 
R-squared values for the linear fits were 0.99 for both MP and ECDV. 
The derived MP and ECDV thresholds were used to determine the mean ECDV and MP 
values in MAR, infarcted myocardium, and normal myocardium (Figure 2-8). As 
expected, mean ECDV in normal myocardium < MAR < infarcted myocardium; mean 
 
Figure 2-7 (top) Mean bias of percent area difference between CI and ECDV plotted 
on the y-axis. ECDV range plotted on the x-axis ECDV threshold of mean bias zero to 
delineate MAR is 0.36 ml/g for acute phase MVO and non-MVO cases. (bottom) 
Mean bias of percent area difference between CI and MP plotted on the y-axis. MP 
range plotted on the x-axis. MP threshold of mean bias zero to delineate infarct is 
0.44 ml/min/g for acute phase MVO cases. Error bars represent the standard error. 
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MP in normal myocardium > MAR > infarcted myocardium. The mean MP  standard 
error of infarcted myocardium, MAR, and normal myocardium were 0.30±0.07 ml/min/g, 
0.81±0.19 ml/min/g, 0.93±0.27 ml/min/g, respectively. The mean ECDV  standard error 
of infarcted myocardium, MAR, and normal myocardium were 0.61±0.12 ml/g, 
0.22±0.07 ml/g, 0.13±0.07 ml/g, respectively. ECDV and MP can distinguish normal and 
infarcted myocardium (p <0.05). ECDV and MP values were also able to distinguish 
infarcted myocardium from MAR (p<0.05); however, no statistical difference was seen in 
ECDV and MP measurements between MAR and normal myocardium. 
2.3.1.3 Combining ECDV and MP to assess MAR 
The apical wall ROI of an ECDV functional map flooded at 0.36 ml/g can identify MAR, 
but cannot identify infarcted myocardium in subjects with MVO (n=5), as shown in 
Figure 2-9, left. However, the apical wall ROI of a MP functional map can identify 
infarcted myocardium at 0.44 ml/min/g. Figure 2-10 (bottom) shows the infarcted 
myocardium determined by the MP threshold match the unidentifiable area on the ECDV 
map at its derived threshold, when the maps are overlaid in subjects with MVO. In a 
subject with no MVO (n=2), the apical wall ROI of a ECDV functional map flooded at 
0.36ml/g can identify MAR, as illustrated in Figure 2-9, right. The apical wall ROI of a 
  
Figure 2-8 Mean MP (ml/min/g) and mean ECDV (ml/g) within different tissue 
states: infarct, at-risk, and normal, determined by MP and ECDV thresholds of 
0.44 ml/min/g and 0.36 ml/g, respectively. Error bars represent standard error of forty-
two slices from 7 pigs. (* denotes p < 0.05). 
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MP functional map flooded at 0.44ml/min/g can identify infarcted myocardium. The 
infarcted myocardium is identified as a small area within a large area of MAR (Figure 2-
10, top) 
 
Figure 2-9 (left) contrast enhanced T1 map, CI difference image, MP, and ECDV 
maps of a single subject (center slice) with MVO and with minimal MVO (right) The 
colored regions correspond to the pixels flooded at specific thresholds. The ECDV 
scale is 0 to 1.2ml/g and MP scale from 0 to 5.0ml/min/g). The white arrows point to 
regions of MVO. 
 
Figure 2-10 (top) subject with minimal MVO (bottom) subject with massive MVO. 
Yellow = infarcted myocardium estimated at MP <0.44ml/min/g. Pink = MAR in non-
MVO cases and salvageable myocardium in MVO cases determined as ECDV 
>0.36ml/g. ECDV scale 0 to 1.2 ml/g and MP scale from 0 to 5.0 ml/min/g. 
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The areas of the thresholded ECDV and MP pixels within the apical wall was compared 
to the MAR area determined from the CI images, grouped into MVO and non-MVO 
cases. A comparison was also performed between the total area of all thresholded pixels 
within the apical wall (ECDV + MP) and the CI-defined MAR area in the group 
subjected to MVO. For the group with no MVO, a comparison was completed between 
the subtracted area of MP thresholded pixels from the area of ECDV thresholded pixels 
within the apical wall ROI (ECDV - MP) and the CI-defined MAR area. Figure 2-11 
(left) demonstrates a significant difference between the area of MAR measured through 
CI difference imaging and MP (p<0.0001) or ECDV (p<0.001) alone. No statistical 
significance was seen between MAR area calculated as the total area of MP and ECDV 
(ECDV + MP), and the MAR area acquired through CI difference image (p>0.05). Figure 
2-11 (right) exhibited significant difference between the area of MAR measured through 
CI difference imaging and MP (p<0.005). In addition, statistical significance was seen 
between MAR area calculated by subtracting MP thresholded pixels from an area of 
ECDV threshold pixels (ECDV-MP), and the MAR area acquired through CI difference 
image (p<0.005). No significant difference was seen MAR area estimated using ECDV 
alone and CI difference image (p>0.05).  
 
Figure 2-11 (left) MVO cases (n=5), comparing the area of infarct (MP), salvageable 
myocardium (ECDV), myocardium at risk (ECDV+MP) to the myocardium at risk 
area measured using CI. (right) non-MVO cases (n=2), comparing the area of infarct 
(MP), myocardium at risk (ECDV), salvageable myocardium (ECDV+MP) to the 
myocardium at risk area measured using CI. Error bars represent the standard error 
amongst each slice between subjects. ** p < 0.005, *** p < 0.001, **** p < 0.0001. 
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2.4 Discussion 
In this study, the ECDV metric derived from the extended JWL tracer kinetic model was 
used as a surrogate marker of edema in AMI. Our results demonstrated that the absolute 
measurements of ECDV were higher in the apical-septal wall relative to the mid-lateral 
wall. These findings were comparable to the patterns of edema measured using the 
model-independent constant infusion CT method and T2 TIRM MR images; and were 
indicative of edema in the extravascular space allowing greater retention of contrast 
(24,26,27,31). Following the validation of myocardial edema as measured by ECDV 
against the model-independent constant infusion CT imaging method, thresholds of MP 
and ECDV were derived to be used to quantify the amount salvageable myocardium. This 
study demonstrated the potential use for functional CT in quantifying the area of 
salvageable myocardium, yielding comparable area of salvageable myocardium estimated 
using the model independent constant infusion CT technique. 
MP and ECDV thresholds determined based on our analysis on subjects of MVO and 
non-MVO, imaged at the acute phase after infarct were 0.44 ml/min/g and 0.36 ml/g, 
respectively. MP less than 0.44 ml/min/g delineated the infarcted myocardium that is 
irreversibly damaged despite revascularization of the occluded artery. On the other hand, 
ECDV values greater than 0.36 ml/g were indicative of MAR or salvageable tissue. 
Although a strict threshold is determined, MP threshold of 0.44   0.02 ml/min/g (or 3% 
deviance from mean bias of zero) and ECDV threshold of 0.36   0.03 ml/g (or 5% 
deviance from mean bias of zero) is an acceptable range to identify areas of MAR and 
infarcted myocardium. 
In injured myocardium with high degree of MVO, the area of infarcted myocardium 
plays a significant role and is prominent within the MAR. The salvageable myocardium 
estimated in MVO cases will be minimal compared to non-MVO cases as the size of 
infarcted myocardium in non-MVO cases with be minimal.  
Previous studies have shown elevation in edema in injured myocardium using T2-w MR 
imaging, which this study has confirmed in the acute and sub-acute phase after AMI 
(23,31-34). In addition, model independent delayed enhancement CT and MR imaging 
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were explored in other studies to assess MAR, with the assumption that retention of 
contrast at equilibrium is a measure of excess space and fluid in the injured myocardium 
17,18,20,22,34). The present study has tested the ECDV technique against a model 
independent constant infusion CT imaging technique, which also assumes the retention of 
contrast in injured myocardium to assess MAR.  
Prolonged coronary artery occlusion in the absence of revascularization treatment leads 
to damage at the microvascular level caused by inflammation, as a result of reperfusion 
(35-37). The presence of MVO has been observed clinically and during animal-model 
studies. The degree of MVO yields prognostic value; hence, MVO is of interest in the 
imaging community during the investigation of salvageable myocardium. Contrast 
enhanced T1 and T2-w MR imaging has been used concomitantly to assess salvageable 
myocardium, and many of these studies were promising (12,33,34). Similar to our results, 
late gadolinium enhanced MR images and gadolinium enhanced T1 maps displayed 
patterns of hyperenhanced myocardium regions within a hypoenhanced myocardium rim. 
The opposite pattern is seen in MR from CT because gadolinium shortens the T1 
relaxation time, making the myocardium with contrast accumulation appear 
hypoenhanced. This pattern detected with contrast enhanced MR is an imaging technique 
used in the clinic to asses MVO (35). Comparable assessment of MVO injury can be 
accomplished using MP and ECDV metrics estimated using the functional CT technique. 
Consequently, the functional CT technique can be used to delineate salvageable 
myocardium similar to MR imaging.  
A limitation of this study was the variation in slice thickness between the MR and CT 
images. The T2 TIRM and contrast enhanced T1-map used for this study were 8 mm in 
slice thickness. In contrast, the CT images were reconstructed at 5 mm slice thicknesses. 
Although the center slices were selected for the validation across modality, slight 
differences in location of the heart can be detected. To address this study limitation, 
images acquired using the four imaging techniques (T1 mapping, T2 TIRM, CI CT, DCE 
CT) should be co-registered with each other to ensure the alignment of the images. 
Another limitation of this study that must be addressed in the future is the lack of non-
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MVO subjects (n=2). To confirm our findings, a greater sample population of non-MVO 
cases is needed. 
Another major limitation that should be addressed in future studies is the prognostic 
value of using ECDV and MP to triage patients for revascularization. Salvageable 
myocardium delineated through ECDV and MP thresholds were not compared to the 
ejection fraction measurements prior to revascularization. Whether or not ECDV and MP 
provide comparable diagnostic and prognostic value as ejection fraction measurements 
should be further investigated.  
2.5 Conclusion 
Partition coefficient, at equilibrium, has been validated (using MRI) as a means to assess 
myocardial viability using CT. Unfortunately, in both MRI and CT, equilibrium between 
tissue and the arterial blood pool can only be reached following prolonged constant 
infusion of contrast agent, rendering such studies impractical for clinical use. The 
functional CT technique proposed by So et al.(29), which introduced the extended JWL 
tracer kinetic model to measure ECDV and MP simultaneously during a single imaging 
session, data are acquired over only 4 minutes. The present study validated ECDV and 
MP measured in an animal model of AMI and identified that a threshold of 0.36 ml/g and 
0.44ml/min/g can delineate area of MAR and infarct myocardium; which can then be 
used to estimate salvageable myocardium. The estimation of salvageable myocardium 
will be useful in triaging patients for revascularization treatment for particularly 
NSTEMI, UA, and late-arriving patients.  
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CHAPTER 3  
3 Conclusions and Future Work 
The purpose of this chapter is to summarize the achievements of my thesis, provide 
general conclusions, address the limitations of the research and provide suggestions for 
the future work that can ultimately lead to the clinical use of DCE-CT in estimating 
salvageable myocardial tissue. 
3.1 Summary of Thesis Work 
AMI is a leading cause of morbidity and mortality in America. A functional imaging 
technique is needed to assess salvageable myocardium for proper patient management for 
revascularization treatment. This will be useful to ensure that the patients who would 
most likely benefit from treatment after MI are guaranteed revascularization treatment 
within the window of opportunity. My thesis investigated the use of functional CT data 
generated from a series of DCE images to which a tracer kinetic model that best 
represented the pathophysiology of AMI was applied to delineate area of salvageable 
myocardium.  
Prior to my contributions to this area of research, Dr. Aaron So and Dr. Ting-Yim Lee 
pioneered the extended JWL model of tracer kinetics to model the exchange of contrast 
between different compartments of an injured myocardium (1-4). They defined this 
distribution of contrast using ECDV and MP, and these parameters were validated against 
the native T1-map and T2-w MR as reference in a previous paper (2). I began my 
contribution to this thesis work by confirming Dr. So’s previous validation study with 
T2-TIRM MR imaging and in addition, compared the ECDV measurements to a model-
independent constant infusion CT-based measurement. ECDV estimated from the 
functional CT technique demonstrated an elevation in edema in injured myocardium 
relative to normal myocardium. These findings validated that ECDV is a surrogate 
measure of myocardial edema.   
After validating ECDV as a surrogate measure of edema, against the previously 
established standard of constant infusion, I investigated the potential clinical utility of the 
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functional CT technique. Prior literature has demonstrated the usefulness of myocardial 
perfusion imaging in detecting injured myocardium following ischemic injury (2-11). MP 
together with the recent advent of ECDV can be used to characterize different 
components of ischemically injured myocardium, which can be used to assess 
salvageable myocardium. Therefore, I evaluated the hypothesis that the combination of 
simultaneously acquired MP and ECDV functional maps would enable the detection of 
infarcted myocardium, MAR, and salvageable myocardium. Firstly, as demonstrated in 
Chapter 2, MP and ECDV thresholds, determined at the acute phase post insult, indicate 
that MP lower than 0.44 ml/min/g represents infarcted myocardium, and ECDV values 
greater than 0.36 ml/g represent MAR area. I concluded that the combination of these two 
quantitative metrics was useful in determining the area of salvageable myocardium. 
Section 3.3.4 will further discuss the importance of estimating both salvageable 
myocardium and MAR for careful triage of patients for revascularization treatment. 
3.2 Study Limitations 
There are several limitations to the study presented in Chapter 2. First, this study was 
limited to seven subjects, which may not suffice given that only two of these subjects 
were non-MVO. The number of animals with non-MVO were underrepresented in this 
study, and more animals are required to represent the patient population in clinical 
settings. Secondly, the porcine animal model was not the ideal model of AMI. The 
animal AMI model consisted of ischemia followed by reperfusion. This can mimic the 
process of MI in UA and NSTEMI patients, but does not represent STEMI patients with 
complete occlusions that do not reperfuse. 
Although the validation of the functional CT technique was completed on acute and sub-
acute phases after MI, evaluation of ECDV and MP to assess salvageable myocardium 
was performed during acute phase after MI. Evaluation of ECDV and MP to estimate 
salvageable myocardium in sub-acute and chronic MI in a greater population of animals 
will be valuable. 
Another technical limitation of this study was the variation in slice thickness between the 
MR and CT images. The T2-w and gadolinium T1-map used for this study were 8 mm 
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thick and the CT images were reconstructed at 5 mm slice thickness. Although the center 
slices were used for analysis, slight differences in location of the heart can be detected.  
The above limitation leads us to our second major limitation of this thesis work, which is 
the absence of co-registration between different imaging methods. For example, slight 
variation in slice location was seen between MR and CT, as well as between DCE-CT 
and CI-CT. The later variation is due to the change in the subject’s heart rate between the 
two acquired scans. This could have been minimized by co-registration of the images, but 
due to the lack of rigidity in cardiac images and cardiac residual motion, attempts to do 
so was unsuccessful. 
3.3 Future Work 
3.3.1 Monochromatic energy level to improve ECDV estimation 
An advantage of dual energy CT used to image the subjects of this study is its ability to 
use two different x-ray energies from a single energy source, to retrospectively 
reconstruct a virtual monochromatic image. As implemented on the GE scanner, virtual 
monochromatic images can be reconstructed at different energy levels. To reduce beam-
hardening artefacts, our previous studies (including the work in my thesis) used virtual 
monochromatic images reconstructed at 70 keV. However, because the k-edge of iodine 
is at 33 keV, we hypothesise that reconstructing virtual monochromatic images at an 
energy closer to the k edge would result in higher contrast to noise ratio (CNR) of iodine 
enhancement in the injured myocardium relative to the normal tissue, ECDV at two 
different monochromatic energy levels were investigated. 
In a preliminary evaluation, I reconstructed virtual monochromatic images at 50 keV for 
six subjects (acute phase post insult), in addition to the 70 keV maps of Chapter 2, and 
generated ECDV maps at 50 and 70 keV.  Representative ECDV maps generated at 50 
and 70 keV are shown in Figure 3-1.  No significant difference was observed in normal 
and injured myocardium between ECDV measurements estimated using retrospectively 
reconstructed 50 keV and 70 keV monochromatic DCE-CT (Figure 3-2).  
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Figure 3-1 ECDV functional maps generated at 70 keV and 50 keV of a single subject. 
Graphs on the right illustrate the normalized time enhancement curves of the injured 
apical septal wall (green) and normal mid-lateral myocardium (purple). 
 
Figure 3-2 ECDV measurements (n=6) compared between images produced using 70 
keV and 50 keV partial scan data.  Error bars represent the standard error of the mean. 
(ns denotes no significance (p > 0.05)). 
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While our preliminary results yielded no statistical significance, further investigation 
must be performed to understand why CNR did not improve in ECDV functional maps 
generated from a monochromatic image closer to the k-edge of iodine.  
3.3.2 Validation of four-minute scan duration in estimating ECDV 
The functional CT technique for estimating ECDV is performed in approximately four 
minutes. It consists of three phases: 1st phase: 22 axial scans at every 1-2 s, 2nd phase: 6 
axial scans at every 14 s, 3rd phase: 4 axial scans at every 30 s. However, other labs have 
emphasized that prolonged scan times - of up to ten minutes – are required to allow for 
the measurement of the greatest amount of contrast retention in the injured myocardium 
(12,13). To validate that our short, four-minute, dynamic imaging session is sufficient for 
accurate estimation of ECDV, future work should compare ECDV measured from scans 
that include a fourth phase that lasts up to 10 min. To provide preliminary validation, I 
analysed data from two subjects, with acute AMI, which were scanned for up to ten 
minutes; the additional 4th phase consisted of 6 axial scans acquired at 60 s intervals. 
ECDV functional maps were generated using all four phases and compare to the ECDV 
functional maps processed using only the three-phase data. The ECDV measurements 
were compared in infarcted and normal myocardium. Figure 3-3 suggests that the 
additional scans acquired up to 10 minutes do not change the measured ECDV. However, 
further study is required to provide statistical significance and to evaluate equivalence in 
cases with minimal perfusion, such as high degree of MVO.  
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3.3.3 Potential application of ECDV in sub-acute and chronic MI  
For the majority of my thesis work, only data from the acute phase (day 3) post insult 
were analyzed. The ECDV and MP thresholds were determined for subjects during the 
acute phase after MI. Previous literature suggests that hemodynamics within the injured 
tissue change as the heart begins its remodeling process (14,15). A major change that 
takes place is the resolution of edema and the development of scar tissue. It would be 
 
Figure 3-3 ECDV map of a two subjects (top and bottom row) at two different scan 
durations. ECDV map corresponding to the short scan duration utilizing three phases 
is shown on the left column and ECDV map corresponding to the long scan duration 
utilizing four phases is shown on the right column. Infarcted myocardium is denoted 
in orange and the normal (remote) myocardium is outlined in red.  
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interesting to test the potentials of ECDV and MP at later phases of MI to monitor the 
change in area of salvageable myocardium for patients who do not receive treatment 
within the ideal revascularization treatment window.  
With DCE-CT, the change in contrast enhancement of the region of interest can be 
monitored over time, and the distribution of contrast within the myocardium can be 
assessed by adopting the JWL model of tracer kinetics. In the case of AMI, this technique 
takes advantage of the edema and inflammation response after reperfusion. ECDV 
quantification is a technique that may prove useful in other disease assessments as well, 
one of which would be scar tissue identification in chronic MI patients. 
 
Figure 3-4 Pathophysiology within infarcted myocardium at chronic MI. This figure 
depicts the development of extracellular matrix composed of high concentration of 
collagen fiber. 
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During the chronic end stages of MI, the necrotic myocardium is replaced by collagenous 
scar tissue—a healing process for the damaged heart (Figure 3-4) (15). The phases leading 
to heart remodeling were divided into three stages by Richardson and colleagues: 
inflammation/necrosis, fibrosis, and long-term heart remodeling. Our ECDV technique can 
take advantage of the space of the extravascular compartment of excessively developed 
extracellular matrix of scarred myocardium. 
Following necrosis, the fibrotic stage can last from one to several weeks depending on the 
degree of injury. During this phase, myofibroblast increase in abundance accompanied by 
upregulation of matrix proteins and contractile abilities, specifically in areas of infarcted 
myocardium. With careful regulations and balance of the above, collagen content 
effectively increases. A compact extracellular matrix is structured by the cross-link of 
many collagen fibers. The volume of space in which contrast agents can accumulate is 
dependent on the density of the collagen fibers of the extracellular matrix. This assumption 
has been tested using cardiac MR to image scar development at chronic stages of MI. 
 
Figure 3-5 ECDV (left) and gadolinium enhanced MR (right) of a subject at acute MI 
and chronic MI. 
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Gadolinium enhanced MR for assessment of chronic MI has become an accepted standard 
in detecting myocardial scar (16-18). Characterization of scar in terms of size and location 
has proven useful in determining the clinical outcome of patients who have undergone 
myocardium damage. Preliminary results of a single subject at the acute and chronic phases 
of MI have demonstrated the potential of ECDV in characterizing chronic MI (Figure 3-
5). Figure 3-5 shows enhancement in the injured myocardium region of a subject’s heart 
imaged in short axis view, corresponding to the hypoenhanced area of a gadolinium 
enhanced T1-map in acute and chronic MI. The retention of contrast that is shown through 
the ECDV and gadolinium T1 map in acute phase MI is a result of edema; however, the 
retention of contrast in injured myocardium at chronic phase MI results from the 
development of fibrotic tissue. Further investigation with greater sample size is required to 
test the use of ECDV in scar detection during chronic phase MI. 
Another technique used in the clinic for scar detection is iodine mapping using dual energy 
CT (19). Clinically, iodine mapping has been proposed to assess perfusion after a bolus 
injection of contrast the hypoenhanced region was delineated on the CMR post gadolinium 
T1 map representing the region affected by edema. The same region of interest was placed 
on two iodine maps of the same subject: (1) at peak enhancement of contrast and (2) at 
 
Figure 3-6 CMR Gd enhanced T1 map (left). ECDV and perfusion functional map 
(top left and right, respectively). Iodine map at delayed phase and at peak contrast 
enhancement (bottom left and right, respectively). 
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delayed phase of injection (Figure 3-6). The preliminary data suggest that myocardial 
absolute perfusion measurements and ECDV values obtained from the functional CT 
technique may be more sensitive and provide quantitative information that may be more 
valuable compared to the iodine map.  
3.3.4 Clinical Translation: triaging patients for revascularization 
treatment  
The clinical motivation of my thesis work is to develop an imaging technique to triage 
AMI patients for revascularization treatment. Upon patient admission to the hospital, they 
are subjected to ECG-tracing and blood work as discussed in section 1.1.2. When the 
patient is diagnosed with STEMI, clinicians can quickly conclude that the patient requires 
urgent revascularization treatment. In situations where the patient remains asymptomatic 
with inconclusive ECG and blood work, clinicians can rely on the functional CT 
technique to estimate ECDV and MP. Quantitative ECDV and MP measurements can 
then be used to delineate MAR and myocardial salvage. Although the functional CT 
technique has the potential to be useful in the clinic, guidelines are required to properly 
triage patients for intervention. 
A useful measure for such guidelines is the calculation of the percentage of area that is 
salvageable myocardium relative to the area of MAR. Once sufficient pre-clinical 
evidence is acquired, a clinical study should be performed to determine a percentage 
threshold of percent area of salvage myocardium to area of MAR to identify which 
patients would most benefit from revascularization treatment.  
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Appendices 
Appendix A: Quality of ECDV functional maps using full scan and partial scan 
retrospective reconstruction 
The previously published paper adopted the use of full-scan reconstruction (1). However, 
retrospective evaluation of the time enhancement curves indicated large variability in 
measured average enhancement at the later time points (phases 2 and 3 of the 
acquisition); see Figure A-1. This observation was consistent with observations made 
during the acquisition where, near the end of the four-minute dynamic scan, subjects 
were “fighting” against the manual breath-hold via ventilator. To reduce the effect of 
motion during acquisition, the same set of raw DCE-CT projection data were 
retrospectively reconstructed to produce partial-scan images for each of the seven 
subjects at the acute phase. As describe in Chapter 2, images were averaged to produce 5-
mm thick slices and the dynamic scan images were registered to each other to minimize 
motion artifact during the single dynamic imaging session (as per the full scan 
reconstructed images). ECDV and MP functional maps were generated (Figure A-1) 
using the extended JWL tracer kinetics model and the values within the myocardial 
regions defined in Chapter 2 were calculated. Analysis was performed only on the ECDV 
data. 
Qualitatively, Figure A-1 shows greater difference between injured and normal 
myocardium is seen in the ECDV maps derived from the partial scan reconstruction than 
the full scan reconstruction. Quantitative comparison of the ECDV values in the apical 
septal (injured) and mid-lateral (normal) walls of the myocardium obtained from the full 
and partial scan are shown in Figure A-2. The figure shows greater difference in ECDV 
between infarcted and normal myocardium when partial scan reconstruction is used (p< 
0.0001) vs. full-scan reconstruction (p<0.05). Therefore, partial scan reconstruction was 
utilized for the all data presented in this thesis. 
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Figure A-1 ECDV and MP maps of a subject using full scan and partial scan 
reconstruction. Graphs on the right illustrate the normalized time enhancement curves 
of the injured apical septal wall (green) and normal mid-lateral myocardium (purple). 
ECDV scale 0 to 1.2 ml/g and MP scale from 0 to 5.0 ml/min/g. 
 
  
Figure A-2 ECDV (ml/g) of infarct and normal myocardium for each subject 
compared using full scan and partial scan reconstruction. (* denote p < 0.05, **** 
denote p < 0.0001). 
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